Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Clinical trial NCT03326310 · RECRUITING
Trial details
- NCT number
- NCT03326310
- Sponsor
- University of Chicago
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-04
- Primary completion
- 2027-09-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.